The FDA recently expanded the approval of the breast cancer drug Kisqali to treat patients with earlier stages of the disease.

Thousands of women diagnosed with early-stage breast cancer will have access to the medication that could help prevent their cancer from coming back.

Dr. Susannah Hills joined “The Rush Hour” on Friday to discuss the drug, mammogram guidelines and AI’s impact on breast cancer detection.